Product NewsLife Sciences SFDA to Install 25 Synbiosis ProtoCOL 3 Colony Counting Systems to Speed-up Testing of Bacterial Vaccines and Antibiotics in China
Product NewsLife Sciences Second ProtoCOL System used at Prestigious UCL Institute of Child Health to Increase Throughput of Vaccine Testing
Product NewsLife Sciences New Scanner to Assist Automation of Large Plates and Increase Throughout of Vaccine and Anti-Microbial Compound Testing
Product NewsSpectroscopy New ProtoCOL 2 UV Imaging Accessory For Fast Counting of Fluorescent Colonies and Plaques
Product NewsLife Sciences Automated Colony Counter used in Modified Ames Test To Precisely Predict the Genotoxicity Effects of Airborne Substances
Product NewsLife Sciences ProtoCOL at Major Food Technology Centre Is Helping to Maintain the Highest Food Safety Standards
Product NewsLife Sciences Make Analysing the Potency of Flu Vaccines Ten Times Faster With ProtoCOL’s New SRD Zone Measurement Features
Product NewsLife Sciences New OPKA Application Features Ensure Speedy Analysis of Pneumococcal Vaccines
Product NewsLife Sciences New Debris Exclusion Features of Automated Colony Counter Saves Food Manufacturers Money by Rapidly Detecting Hazardous Organisms
Product NewsLife Sciences Danish Biotech Reduces Vaccine Testing Time from Two Days to One Hour Using a ProtoCOL System to Assess Vaccine Potency
Product NewsLife Sciences New ProtoCOL UV is world's first automated UV/Visible colony counter and zone sizing system
Product NewsLife Sciences New Colony Counting Software and Validation Procedures from Synbiosis Offer Antimicrobial Manufacturers a Faster Route to GMP Compliance
Product NewsLife Sciences New Microbiology Imaging Software Offers Fast, Accurate Analysis of Colony Numbers and Zone Sizes
Product NewsLife Sciences Major Veterinary Centre to Increase Throughput of Antibiotic Potency Testing Installing Sixteen ProtoCOL Automated Inhibition Zone Sizing Systems
Product NewsLife Sciences Automated Colony Counter Generates Accurate OPKA Assay Results Helping to Speed up Clinical Studies of Pneumococcal Vaccines
